Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold J Burstein

Showing results (61-70 of 252) with videos related to

Pageof 26
Sort By:
Nature Reviews. Clinical Oncology|March 14, 2012
Breast cancer: Neoadjuvant bevacizumab treatment-signal or noise?Harold J Burstein
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Fifty years of systemic therapy for breast cancer: from one size fits all to tailored therapyHarold J Burstein
JAMA|December 6, 2016
Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?Harold J Burstein, Deborah Schrag
JAMA Oncology|February 19, 2026
Lessons From the SONIA Trial on Timing of CDK4/6 Inhibitors in Advanced Breast Cancer-The Sooner, the Better?Carmine Valenza, Harold J Burstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2024
Anthracyclines in Early Breast Cancer: The Long GoodbyeThomas Grinda, Harold J Burstein
The New England Journal of Medicine|July 23, 2015
Nodal Irradiation after Breast-Cancer Surgery in the Era of Effective Adjuvant TherapyHarold J Burstein, Monica Morrow
Annals of Surgical Oncology|April 11, 2018
How Old is Too Old? Breast Cancer Treatment in OctogenariansPedro Exman, Harold J Burstein
Current Treatment Options in Oncology|June 12, 2002
HER2 overexpressing metastatic breast cancerDavid R Spigel, Harold J Burstein
Surgical Oncology Clinics of North America|July 13, 2010
Adjuvant hormonal therapy for early-stage breast cancerHarold J Burstein, Jennifer J Griggs
Lancet (London, England)|March 8, 2011
EMBRACE, eribulin, and new realities of advanced breast cancerNancy U Lin, Harold J Burstein
Pageof 26

Showing results (61-70 of 252) with videos related to

Sort By:
Pageof 26
Nature Reviews. Clinical Oncology|March 14, 2012
Breast cancer: Neoadjuvant bevacizumab treatment-signal or noise?Harold J Burstein
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Fifty years of systemic therapy for breast cancer: from one size fits all to tailored therapyHarold J Burstein
JAMA|December 6, 2016
Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?Harold J Burstein, Deborah Schrag
JAMA Oncology|February 19, 2026
Lessons From the SONIA Trial on Timing of CDK4/6 Inhibitors in Advanced Breast Cancer-The Sooner, the Better?Carmine Valenza, Harold J Burstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2024
Anthracyclines in Early Breast Cancer: The Long GoodbyeThomas Grinda, Harold J Burstein
The New England Journal of Medicine|July 23, 2015
Nodal Irradiation after Breast-Cancer Surgery in the Era of Effective Adjuvant TherapyHarold J Burstein, Monica Morrow
Annals of Surgical Oncology|April 11, 2018
How Old is Too Old? Breast Cancer Treatment in OctogenariansPedro Exman, Harold J Burstein
Current Treatment Options in Oncology|June 12, 2002
HER2 overexpressing metastatic breast cancerDavid R Spigel, Harold J Burstein
Surgical Oncology Clinics of North America|July 13, 2010
Adjuvant hormonal therapy for early-stage breast cancerHarold J Burstein, Jennifer J Griggs
Lancet (London, England)|March 8, 2011
EMBRACE, eribulin, and new realities of advanced breast cancerNancy U Lin, Harold J Burstein
Pageof 26